{"id":"W2607127088","doi":"10.1111/ijcp.12944","title":"Cardiovascular safety in refractory incontinent patients with overactive bladder receiving add-on mirabegron therapy to solifenacin (BESIDE)","year":2017,"lang":"en","type":"article","venue":"International Journal of Clinical Practice","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"Astellas Pharma Europe; Astellas Pharma Global Development; Astellas Pharma","keywords":"Medicine; Mirabegron; Solifenacin; Overactive bladder; Urology; Refractory (planetary science); Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001054984,0.0003487043,0.001138736,0.0002330454,0.0002535194,0.0004967308,0.0002378644,0.0005986063,0.001433093],"category_scores_gemma":[0.001936525,0.0001776787,0.0008047302,0.000207728,0.0002647192,0.0002334243,0.0001861175,0.0007503647,0.0001975827],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003541204,"about_ca_system_score_gemma":0.0003884872,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002684718,"about_ca_topic_score_gemma":0.0007862426,"domain_scores_codex":[0.9993906,0.00035481,0.0000773694,0.00004864967,0.00007934811,0.00004926239],"domain_scores_gemma":[0.9990129,0.0003011109,0.0003653684,0.00004305018,0.00005441311,0.0002230833],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.4796531,0.0120575,0.1393214,0.002993721,0.003547147,0.001527942,0.0008617759,0.001519374,0.04980297,0.0001400687,0.002113445,0.3064614],"study_design_scores_gemma":[0.09460575,0.507905,0.3710289,0.0004410619,0.003633629,0.003345507,0.0005700503,0.00254944,0.01014786,0.0002101573,0.005480121,0.00008251386],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9959145,0.003117883,0.00008696051,0.0001522256,0.0000377474,0.00009286094,0.00007270854,0.0000140549,0.0005110032],"genre_scores_gemma":[0.9981545,0.0009861618,0.0002174476,0.0002000445,0.00009004304,0.00008691307,0.0001138004,0.000001704899,0.0001493844],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001433093,"threshold_uncertainty_score":0.005579352,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06868613109689006,"score_gpt":0.4578434500291966,"score_spread":0.3891573189323065,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}